Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults.
Pasquevich KA, Coria LM, Ceballos A, Mazzitelli B, Rodriguez JM, Demaría A, Pueblas Castro C, Bruno L, Saposnik L, Salvatori M, Varese A, González S, González Martínez VV, Geffner J, Álvarez D; Laboratorio Pablo Cassará R&D and CMC for ARVAC CG consortium; Feleder E, Halabe K, Perez Lera PE, de Oca FM, Vega JC, Lombardo M, Yerino GA, Fló J, Cassataro J. Pasquevich KA, et al. Among authors: gonzalez martinez vv. Nat Commun. 2023 Jul 28;14(1):4551. doi: 10.1038/s41467-023-40272-3. Nat Commun. 2023. PMID: 37507392 Free PMC article. Clinical Trial.
Timing of convalescent plasma administration and 28-day mortality in COVID-19 pneumonia.
González SE, Regairaz L, Salazar MR, Ferrando NS, González Martínez VV, Carrera Ramos PM, Pesci SA, Vidal JM, Kreplak N, Estenssoro E. González SE, et al. Among authors: gonzalez martinez vv. J Investig Med. 2022 Jun;70(5):1258-1264. doi: 10.1136/jim-2021-002158. Epub 2022 Feb 8. J Investig Med. 2022. PMID: 35135872
Risk factors for COVID-19 mortality: The effect of convalescent plasma administration.
Salazar MR, González SE, Regairaz L, Ferrando NS, González Martínez VV, Carrera Ramos PM, Muñoz L, Pesci SA, Vidal JM, Kreplak N, Estenssoro E. Salazar MR, et al. Among authors: gonzalez martinez vv. PLoS One. 2021 Apr 29;16(4):e0250386. doi: 10.1371/journal.pone.0250386. eCollection 2021. PLoS One. 2021. PMID: 33914780 Free PMC article.
Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case-control study.
González S, Olszevicki S, Gaiano A, Salazar M, Regairaz L, Varela Baino AN, Bartel E, Varela T, González Martínez VV, Pesci S, Marín L, Irassar JI, Ceriani L, Garcia E, Kreplak N, Estenssoro E, Marsico F. González S, et al. Among authors: gonzalez martinez vv. Lancet Reg Health Am. 2023 Sep 28;27:100607. doi: 10.1016/j.lana.2023.100607. eCollection 2023 Nov. Lancet Reg Health Am. 2023. PMID: 37808936 Free PMC article.